Tumour necrosis factor receptor 1 (TNFR1) plays a critical role in host defence and inflammation. We have identified a membrane proximal region (aa 218-324) of TNFR1 that restricts surface expression. This was prompted by comparing the dominant-negative properties of a C-terminal truncation of TNFR1 with a point mutant that prevents signalling. C-terminal truncation (aa 218-426) generates a better dominant-negative TNFR1 mutant than inactivation of the death domain by point mutation. The increased dominant-negative activity correlates with increased cell surface expression. The membrane proximal region is the most important region of the receptor for restricting expression
The signalling cascade, produced after THF ligand binding, involves the recruitment of many differen...
AbstractThe 60 kDa tumor necrosis factor receptor (TNFR60) is regarded as the major signal transduce...
Objective: Tumor necrosis factor receptor–associated periodic syndrome (TRAPS) is an autoinflammato...
Tumour necrosis factor receptor 1 (TNFR1) plays a critical role in host defence and inflammation. We...
AbstractTumour necrosis factor receptor 1 (TNFR1) plays a critical role in host defence and inflamma...
Tumour necrosis factor receptor-associated periodic syndrome (TRAPS) results from point mutations in...
Tumour necrosis factor receptor-associated periodic syndrome (TRAPS) results from point mutations in...
AbstractTumour necrosis factor receptor-associated periodic syndrome (TRAPS) results from point muta...
TNF receptor associated periodic syndrome (TRAPS) is an autoinflammatory disease involving recurrent...
Pleiotropic TNF activities are mediated through the two cell surface receptors (TNFRs). Both are tra...
In order to define the active site(s) of human tumour necrosis factor (hTNF), we mutagenized its gen...
International audienceTumor necrosis factor (TNF) is a potent multi-functional cytokine with a homeo...
TNFR1 (tumor necrosis factor receptor 1) localizes to caveolae of human endothelial-derived EA.hy926...
TNFR1 ( tumor necrosis factor receptor 1) localizes to caveolae of human endothelial-derived EA.hy92...
The signalling cascade, produced after THF ligand binding, involves the recruitment of many differen...
AbstractThe 60 kDa tumor necrosis factor receptor (TNFR60) is regarded as the major signal transduce...
Objective: Tumor necrosis factor receptor–associated periodic syndrome (TRAPS) is an autoinflammato...
Tumour necrosis factor receptor 1 (TNFR1) plays a critical role in host defence and inflammation. We...
AbstractTumour necrosis factor receptor 1 (TNFR1) plays a critical role in host defence and inflamma...
Tumour necrosis factor receptor-associated periodic syndrome (TRAPS) results from point mutations in...
Tumour necrosis factor receptor-associated periodic syndrome (TRAPS) results from point mutations in...
AbstractTumour necrosis factor receptor-associated periodic syndrome (TRAPS) results from point muta...
TNF receptor associated periodic syndrome (TRAPS) is an autoinflammatory disease involving recurrent...
Pleiotropic TNF activities are mediated through the two cell surface receptors (TNFRs). Both are tra...
In order to define the active site(s) of human tumour necrosis factor (hTNF), we mutagenized its gen...
International audienceTumor necrosis factor (TNF) is a potent multi-functional cytokine with a homeo...
TNFR1 (tumor necrosis factor receptor 1) localizes to caveolae of human endothelial-derived EA.hy926...
TNFR1 ( tumor necrosis factor receptor 1) localizes to caveolae of human endothelial-derived EA.hy92...
The signalling cascade, produced after THF ligand binding, involves the recruitment of many differen...
AbstractThe 60 kDa tumor necrosis factor receptor (TNFR60) is regarded as the major signal transduce...
Objective: Tumor necrosis factor receptor–associated periodic syndrome (TRAPS) is an autoinflammato...